In this line of evidence, we found that FTO variants associated with BMI only remained in BD patients, even when the BDC group had higher rates of obesity, which suggests that the effect of these variants modulating BMI could be higher in BD patients than in non‐BD obese individuals. Here, FTO is linked to obesity due to melanocortin 4 receptor deficiency.